Inflection Point Acquisition Corp. II, POET Technologies, Wolfspeed, Avalo Therapeutics, Direxion Daily PLTR Bear 1X Shares, Ernexa Therapeutics, and Inflection Point Acquisition are the seven Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of companies with relatively small market capitalizations—commonly defined as firms with total market values roughly between $300 million and $2 billion, though exact cutoffs vary by index and over time. Investors view them as offering higher growth potential but also greater volatility, lower liquidity, and higher risk compared with mid- and large-cap stocks. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.
Inflection Point Acquisition Corp. II (IPXX)
Read Our Latest Research Report on IPXX
POET Technologies (POET)
POET Technologies Inc. designs, develops, manufactures, and sells discrete and integrated opto-electronic solutions in Canada, the United States, Singapore, and China. It offers integration solutions based on the POET Optical Interposer, a novel platform that allows the seamless integration of electronic and photonic devices into a single multi-chip module using advanced wafer-level semiconductor manufacturing techniques.
Read Our Latest Research Report on POET
Wolfspeed (WOLF)
Wolfspeed, Inc. operates as a powerhouse semiconductor company focuses on silicon carbide and gallium nitride (GaN) technologies in Europe, Hong Kong, China, rest of Asia-Pacific, the United States, and internationally. It offers silicon carbide and GaN materials, including silicon carbide bare wafers, epitaxial wafers, and GaN epitaxial layers on silicon carbide wafers to manufacture products for RF, power, and other applications.
Read Our Latest Research Report on WOLF
Avalo Therapeutics (AVTX)
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation in the Unites States. The company's drug candidates include AVTX-009, an Anti-IL-1ß monoclonal antibody which is under Phase I targeting inflammatory diseases; and AVTX-008, a fully human B and T lymphocyte attenuator agonist fusion protein for the treatment of immune dysregulation disorders.
Read Our Latest Research Report on AVTX
Direxion Daily PLTR Bear 1X Shares (PLTD)
Read Our Latest Research Report on PLTD
Ernexa Therapeutics (ERNA)
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited.
Read Our Latest Research Report on ERNA
Inflection Point Acquisition (IPAX)
Read Our Latest Research Report on IPAX
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Inflection Point Acquisition Corp. II, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inflection Point Acquisition Corp. II wasn't on the list.
While Inflection Point Acquisition Corp. II currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
